# Analysis of Human Papillomavirus-HPV-18 and HPV-45 Type-specific variants in a contemporary cohort of individuals with cervical disease in Ghana

**Authors:** Gladys Kaba, Andrew Stevenson, Samuel A Sakyi, Thomas O Konney, Nicholas A Titiloye, Samuel A Oppong, Kwabena Amo-Antwi, Francis Agyemang-Yeboah, Kate Cuschieri, Sheila V Graham

PMC · DOI: 10.4314/gmj.v58i4.9 · 2024-12-01

## TL;DR

This study identifies specific variants of HPV-18 and HPV-45 in cervical cancer patients in Ghana, highlighting the prevalence of certain lineages and sublineages.

## Contribution

The study provides new data on HPV-18 and HPV-45 lineage-specific variants and their E6/E7 SNPs in Ghanaian cervical cancer cases.

## Key findings

- HPV-45 sublineage-A1 and HPV-18 lineage-B are dominant in Ghanaian cervical cancer cases.
- Rare lineage-C HPV-18 variants were also detected, indicating genetic diversity.
- E6/E7 SNPs were identified in HPV-18 and HPV-45 variants, offering insights for therapeutic strategies.

## Abstract

E6 and E7 DNA sequence profile of HPV-18 and HPV-45 lineage/sublineage variants in Ghana.

A cross-sectional study.

Obstetrics/Gynaecology Directorate, Komfo Anokye Teaching Hospital, Kumasi and Department of Radiotherapy/Nuclear Medicine and the Family Planning Unit, Korle-Bu Teaching Hospital, Accra.

207 individuals referred with clinical suspicion of cervical cancer (CxCa) or confirmed CxCa/precancer cases.

Cervical swabs were collected (from October 2018 to November 2020) from individuals, with L1 DNA positivity for HPV-18(40 samples) and/or HPV-45(28 samples), out of 207 samples tested for 24-HPV-genotypes. DNA was extracted from a convenience sample and HPV-E6/E7-PCR (33/40-HPV-18-+ve- or 20/28-HPV-45-+ve samples), sequencing, and BLAST analysis was carried out.

After PCR amplification, the E6/E7 gene regions of 26 out of 33(HPV-18+ve) samples and ten (10) out of 20 (HPV-45+ve) samples were eligible for sequencing. For HPV-18 variants, 24 out of 26 samples (92.31%) were of lineage-B/C, including samples of lineage-C and 22 samples of lineage-B (out of which ten (10) samples were with E7-SNP-C665T). Nine out of ten HPV-45 variants were sublineage-A1, of which two (2) samples harboured both E6-SNPs-C134T and C4I7T including one sample with E6-SNPs-C134T, G415C, C4I7T detected together.

Our study confirms a dominance of HPV-45-sublineage-A1 and HPV-18-lineage-B (with rare occurrence of Africa-specific HPV-18-lineage-C) variants in Ghana. Our study provides preliminary data on E6/E7 SNPs of HPV-18 and HPV-45 lineages and sublineages among CxCa cases in Ghana. We hope our data will inform future studies on pattern and distribution of HPV type-specific nucleotide changes that can be useful for therapeutic intervention.

UK Government, (GK) Commonwealth Split-Site Scholarship with research support grant, number GHCN201823. GK also received Ghana public universities senior members book & research allowance, for research activities carried out in Ghana.

## Linked entities

- **Genes:** e6 (E6 protein) [NCBI Gene 929651], E7 (E7) [NCBI Gene 944319]
- **Diseases:** cervical cancer (MONDO:0002974)

## Full-text entities

- **Diseases:** cervical cancer (MESH:D002583), cervical disease (MESH:D002575)
- **Species:** Human papillomavirus (species) [taxon 10566]
- **Mutations:** G415C, C665T, C134T

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12203745/full.md

---
Source: https://tomesphere.com/paper/PMC12203745